All In MedTech

Device Trial Radar · NCT03943680

Plasma Rich in Growth Factors in Post-extraction Sockets

Clinical Behavior and Molecular Pathways of PRGF in Post-extraction Sockets

Last checked: Nov 19, 2026Latest source record: May 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

30

Actual

Start

Mar 4, 2019

Primary completion

Nov 18, 2024

Study completion Oct 30, 2025

Sponsor

Lead sponsor
Universidad de GranadaAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
BTI Biotechnology Institute
First posted
May 9, 2019

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to compare the clinical success, radiographical volume maintenance and histological bone regeneration after using either a bovine bone xenograft or an autogenous platelet rich plasma enrich in growth factors, known as Endoret®-PRGF®.

Conditions

  • Tooth Extraction
  • Dental Implants

Interventions

  • PRGFDevice

    After tooth extraction, the socket will be grafted with PRGF-Endoret

  • ABBDevice

    After tooth extraction, the socket will be grafted with Geistlich Bio-Oss® Collagen

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Alveolar bone change in Cone Beam Computerized TomographyTime frame: Baseline and 4 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Facultad de Odontología

    Granada, Granada, Spain

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.